White label ELPA - ClinicalTrials.eu

Study on the Effectiveness of Polatuzumab, Bendamustine, and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma

Not recruiting

2 1 1 1
Investigated diseases:
- Mantle cell lymphoma
Investigated drugs:
Study of BT-001 and Pembrolizumab for Patients with Advanced Solid Tumors, Including Sarcoma, Merkel Cell Carcinoma, Melanoma, Breast, and Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
Study on Urea for Treating Low Sodium Levels in Patients with Brain Hemorrhage

Not recruiting

2 1
Investigated diseases:
- Hyponatraemia
- Subarachnoid haemorrhage
Investigated drugs:
- Urea
Study on Baricitinib for New-Onset Polymyalgia Rheumatica Patients to Reduce Steroid Use

Not recruiting

3 1 1
Investigated diseases:
- Polymyalgia rheumatica
Investigated drugs:
- Baricitinib
Study on Dapagliflozin to Reduce Heart Damage from Chemotherapy in Breast Cancer Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Chemotherapy cardiotoxicity attenuation
Investigated drugs:
- Dapagliflozin
Study on Daratumumab for Multiple Myeloma Patients with Minimal Residual Disease Reappearance or Biochemical Relapse

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
- Daratumumab
Study of Durvalumab and Chemo-Immunotherapy for Patients with Stage III Unresectable Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Durvalumab
Study Comparing Lenalidomide, Carfilzomib, and Dexamethasone with Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study on the Effectiveness of Venetoclax and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia

Not recruiting

2 1 1 1
Investigated diseases:
- Chronic lymphocytic leukaemia
Investigated drugs:
- Venetoclax
- Rituximab
Study on Genotype-Guided Treatment with Carbasalate Calcium, Telmisartan, and Rivaroxaban for Patients with Peripheral Arterial Disease

Not recruiting

3 1 1 1
Investigated diseases:
- Peripheral arterial occlusive disease
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies